이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

AddLife 관리

관리 기준 확인 2/4

AddLife's CEO는 Fredrik Dalborg, Jan2022 에 임명되었습니다 의 임기는 2.42 년입니다. 총 연간 보상은 SEK 8.70M, 56.8% 로 구성됩니다. 56.8% 급여 및 43.2% 보너스(회사 주식 및 옵션 포함). 는 € 353.16K 가치에 해당하는 회사 주식의 0.026% 직접 소유합니다. 353.16K. 경영진과 이사회의 평균 재임 기간은 각각 0.8 년과 8.8 년입니다.

주요 정보

Fredrik Dalborg

최고 경영자

SEK 8.7m

총 보상

CEO 급여 비율	56.8%
CEO 임기	2.7yrs
CEO 소유권	0.03%
경영진 평균 재임 기간	1.1yrs
이사회 평균 재임 기간	9yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Fredrik Dalborg 의 보수는 AddLife 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	n/a	n/a	SEK 118m
Mar 31 2024	n/a	n/a	SEK 78m
Dec 31 2023	SEK 9m	SEK 5m	SEK 190m
Sep 30 2023	n/a	n/a	SEK 292m
Jun 30 2023	n/a	n/a	SEK 387m
Mar 31 2023	n/a	n/a	SEK 429m
Dec 31 2022	SEK 6m	SEK 2m	SEK 480m

보상 대 시장: Fredrik 의 총 보상 ($USD 834.00K ) German 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 1.53M ).

보상과 수익: Fredrik 의 보상은 작년에 20% 이상 증가한 반면 회사 수익은 20% 이상 감소했습니다.

CEO

Fredrik Dalborg (52 yo)

2.7yrs

테뉴어

SEK 8,704,000

보상

Mr. Fredrik Dalborg serves as President & Chief Executive Officer at AddLife AB (publ) since 2022. Mr. Dalborg served as Managing Director for North America at Xvivo Perfusion AB (publ) since December 15,...

리더십 팀

이름	위치	테뉴어	보상	소유권
Fredrik Dalborg	President & CEO	2.7yrs	SEK 8.70m	0.026% SEK 458.9k
Christina Rubenhag	Chief Financial Officer	2.7yrs	데이터 없음	0.0053% SEK 93.3k
Julie O'Leary	Investor Relations Manager	less than a year	데이터 없음	데이터 없음
Christian Karlsson	Head of Business Development	3.7yrs	데이터 없음	데이터 없음
Per Wahlstedt	Head of Organic Growth & Profitability	2.7yrs	데이터 없음	데이터 없음
Timmy Rosendal	Head of Sustainability	1.1yrs	데이터 없음	데이터 없음
Ioana Dragan	Head of Financial Control	less than a year	데이터 없음	데이터 없음
Jamilah Wass	Group Financial Controller	no data	데이터 없음	데이터 없음
Nichlas Essner	Group Business Controller	less than a year	데이터 없음	데이터 없음
Malin Lindh	Group Business Controller	less than a year	데이터 없음	데이터 없음

1.1yrs

평균 재임 기간

경험이 풍부한 관리: 1AD1 의 관리팀은 경험 (평균 재직 기간 0.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Birgit Norinder	Independent Director	9yrs	SEK 350.00k	0.010% SEK 181.6k
Eva Elmstedt	Independent Director	3.3yrs	SEK 350.00k	0.0041% SEK 71.8k
Johan Sjo	Independent Chairman	9.5yrs	SEK 700.00k	0.14% SEK 2.4m
Håkan Roos	Independent Director	9.2yrs	SEK 350.00k	4.76% SEK 83.3m
Eva Nilsagard	Independent Director	8.8yrs	SEK 500.00k	0.0046% SEK 80.0k
Stefan Hedelius	Independent Director	9yrs	SEK 350.00k	0.024% SEK 424.3k

9.0yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: 1AD1 의 이사회는 경험(평균 재직 기간 8.8 년)으로 간주됩니다.

AddLife 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Insufficient new directors

Independent Director recently bought €2.8m worth of stock

AddLife AB (publ), Annual General Meeting, May 08, 2024

Independent Director recently bought €1.0m worth of stock

President & CEO recently bought €12k worth of stock

President & CEO recently bought €10.0k worth of stock

Recent updates

Second quarter 2024 earnings released: EPS: kr0.59 (vs kr0.26 in 2Q 2023)

AddLife AB (publ) to Report Q1, 2025 Results on Apr 25, 2025

Insufficient new directors

AddLife AB (publ) Approves Dividend, Payable on 16 May 2024

First quarter 2024 earnings released: EPS: kr0.51 (vs kr1.43 in 1Q 2023)

AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025

Independent Director recently bought €2.8m worth of stock

AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024

Dividend of kr0.50 announced

Full year 2023 earnings released: EPS: kr1.56 (vs kr3.94 in FY 2022)

AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

Investor sentiment improves as stock rises 26%

Third quarter 2023 earnings released

AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024

Now 22% undervalued after recent price drop

AddLife AB (publ), Annual General Meeting, May 08, 2024

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 33%

New minor risk - Dividend sustainability

Second quarter 2023 earnings released: EPS: kr0.27 (vs kr0.61 in 2Q 2022)

Investor sentiment deteriorates as stock falls 15%

Independent Director recently bought €1.0m worth of stock

Addlife AB (Publ) Declares Dividend

Investor sentiment improves as stock rises 22%

Upcoming dividend of kr1.20 per share at 1.0% yield

First quarter 2023 earnings released

President & CEO recently bought €12k worth of stock

President & CEO recently bought €10.0k worth of stock

Full year 2022 earnings released: EPS: kr3.94 (vs kr6.02 in FY 2021)

AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022

Håkan Roos acquired a 0.246285% stake in AddLife AB (publ) for SEK 30 million.

Third quarter 2022 earnings released

AddLife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023

AddLife AB (publ) to Report Q1, 2023 Results on Apr 26, 2023

Now 22% undervalued after recent price drop

Second quarter 2022 earnings released

Now 20% undervalued after recent price drop

Investor sentiment deteriorated over the past week

CFO & Business Area Manager of Medtech recently sold €808k worth of stock

Addlife AB (Publ) Approves Dividend, Payable on 12 May 2022

Upcoming dividend of kr2.00 per share

AddLife AB (publ) Appoints Fredrik Dalborg as President

Full year 2021 earnings released: EPS: kr6.02 (vs kr4.62 in FY 2020)

AddLife AB (publ) (OM: ALIF B) acquired O'Flynn Medical Limited.

Addlife AB (Publ) Proposes Dividend, Payable on 12 May 2022

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) completed the acqusitions of Telia Health Monitoring.

President & CEO recently bought €552k worth of stock

Addlife AB (Publ) Proposes Dividend

Addlife AB (Publ) Announces Step Down of Kristina Willgård as Chief Executive Officer

AddLife AB (publ) (OM:ALIF B) completed the acquisition of MBA Incorporado S.A from Alantra Private Equity.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire MBA Incorporado S.A from Alantra Private Equity for approximately €110 million.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Telia Health Monitoring.

Investor sentiment deteriorated over the past week

Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million.

President & CEO recently sold €3.2m worth of stock

Investor sentiment improved over the past week

Third quarter 2021 earnings released

Independent Chairman recently sold €1.1m worth of stock

AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV.

Investor sentiment improved over the past week

Independent Chairman recently sold €689k worth of stock

Second quarter 2021 earnings released: EPS kr1.46 (vs kr1.07 in 2Q 2020)

Investor sentiment improved over the past week

Chief Financial Officer recently sold €1.4m worth of stock

Independent Director has left the company

AddLife AB (publ) Approves Dividend, Payable on 12 May 2021